The use of aqueous humor cfDNA for low-pass whole genome sequencing as a clinical test to identify intraocular retinoblastoma recurrence

Douglas Chigane, Drishti Pandya, Brianne Brown, Michelle Lin, Alexander Tseng, Rachana Shah, Rima Jubran, Matthew Snider, Patrick Peng, Muskaan Singh, Venkata Yellapantula, Jaclyn A. Biegel, Liya Xu, Jesse Berry

Open source

DOI
10.61340/uahctirbr
Published
2025-06-03
Container
ScienceBank
Publisher
Intelligent Science Group Inc
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.61340/uahctirbr,
  title = {The use of aqueous humor cfDNA for low-pass whole genome sequencing as a clinical test to identify intraocular retinoblastoma recurrence},
  author = {Douglas Chigane and Drishti Pandya and Brianne Brown and Michelle Lin and Alexander Tseng and Rachana Shah and Rima Jubran and Matthew Snider and Patrick Peng and Muskaan Singh and Venkata Yellapantula and Jaclyn A. Biegel and Liya Xu and Jesse Berry},
  year = {2025},
  journal = {ScienceBank},
  doi = {10.61340/uahctirbr},
  url = {https://doi.org/10.61340/uahctirbr}
}

RIS

TY  - JOUR
TI  - The use of aqueous humor cfDNA for low-pass whole genome sequencing as a clinical test to identify intraocular retinoblastoma recurrence
AU  - Douglas Chigane
AU  - Drishti Pandya
AU  - Brianne Brown
AU  - Michelle Lin
AU  - Alexander Tseng
AU  - Rachana Shah
AU  - Rima Jubran
AU  - Matthew Snider
AU  - Patrick Peng
AU  - Muskaan Singh
AU  - Venkata Yellapantula
AU  - Jaclyn A. Biegel
AU  - Liya Xu
AU  - Jesse Berry
PY  - 2025
JO  - ScienceBank
DO  - 10.61340/uahctirbr
UR  - https://doi.org/10.61340/uahctirbr
ER  - 

APA

Chigane, D., Pandya, D., Brown, B., Lin, M., Tseng, A., Shah, R., Jubran, R., Snider, M., Peng, P., Singh, M., Yellapantula, V., Biegel, J. A., Xu, L., & Berry, J. (2025). The use of aqueous humor cfDNA for low-pass whole genome sequencing as a clinical test to identify intraocular retinoblastoma recurrence. ScienceBank. https://doi.org/10.61340/uahctirbr

Source records